Tokyo Tape
Sign in
← Ain Holdings

Quarterly report · Q2

9627.TEDINET S100SH2U
Period2023-05-01 → 2023-10-31
Filed2023-12-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥193.7bn2023-05-01 → 2023-10-31Cons.Net sales
Revenue¥358.7bn2022-05-01 → 2023-04-30Cons.Net sales (5-year summary)
Revenue¥171.2bn2022-05-01 → 2022-10-31Cons.Net sales
Operating income¥8.7bn2023-05-01 → 2023-10-31Cons.Operating income
Operating income¥6.8bn2022-05-01 → 2022-10-31Cons.Operating income
Ordinary income¥9.3bn2023-05-01 → 2023-10-31Cons.Ordinary income
Ordinary income¥17.1bn2022-05-01 → 2023-04-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥7.3bn2022-05-01 → 2022-10-31Cons.Ordinary income
Profit before tax¥9.4bn2023-05-01 → 2023-10-31Cons.Income before income taxes
Profit before tax¥7.2bn2022-05-01 → 2022-10-31Cons.Income before income taxes
Net income (owners)¥5.3bn2023-05-01 → 2023-10-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥9.2bn2022-05-01 → 2023-04-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥3.8bn2022-05-01 → 2022-10-31Cons.Profit loss attributable to owners of parent
Net income¥5.2bn2023-05-01 → 2023-10-31Cons.Profit loss
Net income¥3.8bn2022-05-01 → 2022-10-31Cons.Profit loss
Total assets¥242.9bnat 2023-10-31Cons.Assets
Total assets¥231.8bnat 2023-04-30Cons.Assets
Total assets¥231.3bnat 2022-10-31Cons.Total assets (5-year summary)
Total liabilities¥113.1bnat 2023-10-31Cons.Liabilities
Total liabilities¥105.2bnat 2023-04-30Cons.Liabilities
Net assets / equity¥129.8bnat 2023-10-31Cons.Net assets
Net assets / equity¥126.5bnat 2023-04-30Cons.Net assets
Net assets / equity¥120.9bnat 2022-10-31Cons.Net assets (5-year summary)
Cash and deposits¥50.5bnat 2023-10-31Cons.Cash and deposits
Cash and deposits¥46.8bnat 2023-04-30Cons.Cash and deposits
Cash & equivalents¥50.3bnat 2023-10-31Cons.Cash and cash equivalents
Cash & equivalents¥46.2bnat 2023-04-30Cons.Cash and cash equivalents
Cash & equivalents¥43.5bnat 2022-10-31Cons.Cash and cash equivalents
Cash & equivalents¥59.5bnat 2022-04-30dCons.Cash and cash equivalents
Operating cash flow¥14.1bn2023-05-01 → 2023-10-31Cons.Net cash provided by used in operating activities
Operating cash flow¥20.3bn2022-05-01 → 2023-04-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥8.5bn2022-05-01 → 2022-10-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥5.8bn2023-05-01 → 2023-10-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥22.3bn2022-05-01 → 2023-04-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥18.6bn2022-05-01 → 2022-10-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥4.2bn2023-05-01 → 2023-10-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥11.2bn2022-05-01 → 2023-04-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥5.8bn2022-05-01 → 2022-10-31Cons.Net cash provided by used in financing activities
EPS (basic)¥149.662023-05-01 → 2023-10-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥88.732023-08-01 → 2023-10-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥262.872022-05-01 → 2023-04-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥108.322022-05-01 → 2022-10-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥59.782022-08-01 → 2022-10-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio53.4%at 2023-10-31Cons.Equity to asset ratio (5-year summary)
Equity ratio54.6%at 2023-04-30Cons.Equity to asset ratio (5-year summary)
Equity ratio52.2%at 2022-10-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 34
SegmentItemPeriodValue
Otherother segmentsrevenue2023-05-01 → 2023-10-31¥5.7bn
Otherother segmentsrevenue external2023-05-01 → 2023-10-31¥5.7bn
Otherother segmentsrevenue intersegment2023-05-01 → 2023-10-31¥24m
Otherother segmentssegment ordinary income2023-05-01 → 2023-10-31−¥49m
Reconciling Itemsreconcilingrevenue2023-05-01 → 2023-10-31−¥24m
Reconciling Itemsreconcilingrevenue intersegment2023-05-01 → 2023-10-31−¥24m
Reconciling Itemsreconcilingsegment ordinary income2023-05-01 → 2023-10-31−¥4.4bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentrevenue2023-05-01 → 2023-10-31¥173.2bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentrevenue external2023-05-01 → 2023-10-31¥173.2bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentsegment ordinary income2023-05-01 → 2023-10-31¥12.5bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentrevenue2023-05-01 → 2023-10-31¥14.8bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentrevenue external2023-05-01 → 2023-10-31¥14.8bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentsegment ordinary income2023-05-01 → 2023-10-31¥1.3bn
—segment totalrevenue2023-05-01 → 2023-10-31¥193.8bn
—segment totalrevenue external2023-05-01 → 2023-10-31¥193.7bn
—segment totalrevenue intersegment2023-05-01 → 2023-10-31¥24m
—segment totalsegment ordinary income2023-05-01 → 2023-10-31¥13.8bn
Otherother segmentsrevenue2022-05-01 → 2022-10-31¥5.8bn
Otherother segmentsrevenue external2022-05-01 → 2022-10-31¥5.8bn
Otherother segmentsrevenue intersegment2022-05-01 → 2022-10-31¥31m
Otherother segmentssegment ordinary income2022-05-01 → 2022-10-31−¥18m
Reconciling Itemsreconcilingrevenue2022-05-01 → 2022-10-31−¥31m
Reconciling Itemsreconcilingrevenue intersegment2022-05-01 → 2022-10-31−¥31m
Reconciling Itemsreconcilingsegment ordinary income2022-05-01 → 2022-10-31−¥3.8bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentrevenue2022-05-01 → 2022-10-31¥153.2bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentrevenue external2022-05-01 → 2022-10-31¥153.2bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentsegment ordinary income2022-05-01 → 2022-10-31¥10.8bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentrevenue2022-05-01 → 2022-10-31¥12.2bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentrevenue external2022-05-01 → 2022-10-31¥12.2bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentsegment ordinary income2022-05-01 → 2022-10-31¥349m
—segment totalrevenue2022-05-01 → 2022-10-31¥171.2bn
—segment totalrevenue external2022-05-01 → 2022-10-31¥171.2bn
—segment totalrevenue intersegment2022-05-01 → 2022-10-31¥31m
—segment totalsegment ordinary income2022-05-01 → 2022-10-31¥11.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 555
ItemContextValueUnit
Dividends income noiPrior1YTDDuration31000000JPY
Dividends income noiCurrentYTDDuration26000000JPY
Commission fee noiPrior1YTDDuration10000000JPY
Commission fee noiCurrentYTDDuration5000000JPY
Real estate rent noiPrior1YTDDuration97000000JPY
Real estate rent noiCurrentYTDDuration149000000JPY
Fiduciary obligation fee noiPrior1YTDDuration106000000JPY
Fiduciary obligation fee noiCurrentYTDDuration117000000JPY
Subsidy income noiPrior1YTDDuration96000000JPY
Subsidy income noiCurrentYTDDuration192000000JPY
Other noiPrior1YTDDuration320000000JPY
Other noiCurrentYTDDuration248000000JPY
Non operating incomePrior1YTDDuration686000000JPY
Non operating incomeCurrentYTDDuration761000000JPY
Interest expenses noePrior1YTDDuration27000000JPY
Interest expenses noeCurrentYTDDuration17000000JPY
Loss on transfer of receivables noePrior1YTDDuration48000000JPY
Loss on transfer of receivables noeCurrentYTDDuration55000000JPY
Rent expenses on real estates noePrior1YTDDuration42000000JPY
Rent expenses on real estates noeCurrentYTDDuration61000000JPY
Other noePrior1YTDDuration68000000JPY
Other noeCurrentYTDDuration37000000JPY
Non operating expensesPrior1YTDDuration187000000JPY
Non operating expensesCurrentYTDDuration172000000JPY
Ordinary incomePrior1YTDDuration7285000000JPY
Ordinary incomeCurrentYTDDuration9338000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration2000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration357000000JPY
Gain on transfer of business eiPrior1YTDDuration46000000JPY
Gain on transfer of business eiCurrentYTDDuration2000000JPY
Surrender value of insurance eiPrior1YTDDuration35000000JPY
Surrender value of insurance eiCurrentYTDDuration0JPY
Other eiPrior1YTDDuration1000000JPY
Other eiCurrentYTDDuration3000000JPY
Extraordinary incomePrior1YTDDuration86000000JPY
Extraordinary incomeCurrentYTDDuration363000000JPY
Loss on sales and retirement of noncurrent assets elPrior1YTDDuration118000000JPY
Loss on sales and retirement of noncurrent assets elCurrentYTDDuration106000000JPY
Impairment loss elPrior1YTDDuration63000000JPY
Impairment loss elCurrentYTDDuration153000000JPY
Other elPrior1YTDDuration23000000JPY
Other elCurrentYTDDuration13000000JPY
Extraordinary lossPrior1YTDDuration204000000JPY
Extraordinary lossCurrentYTDDuration274000000JPY
Income before income taxesPrior1YTDDuration7167000000JPY
Income before income taxesCurrentYTDDuration9427000000JPY
Income taxesPrior1YTDDuration3370000000JPY
Income taxesCurrentYTDDuration4182000000JPY
Profit lossPrior1YTDDuration3796000000JPY
Profit lossCurrentYTDDuration5244000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-04-30pass
balance sheet identityconsolidated 2023-10-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-04-30pass
statement vs summary · net assetsconsolidated 2023-10-31pass
statement vs summary · net income attributable to parentconsolidated 2022-05-01/2022-10-31pass
statement vs summary · net income attributable to parentconsolidated 2023-05-01/2023-10-31pass
statement vs summary · operating cash flowconsolidated 2022-05-01/2022-10-31pass
statement vs summary · operating cash flowconsolidated 2023-05-01/2023-10-31pass
statement vs summary · revenueconsolidated 2022-05-01/2022-10-31pass
statement vs summary · revenueconsolidated 2023-05-01/2023-10-31pass
statement vs summary · total assetsconsolidated 2023-04-30pass
statement vs summary · total assetsconsolidated 2023-10-31pass